Lv6
1760 积分 2022-12-29 加入
Update on Management of Squamous Cell Esophageal Cancer
10小时前
待确认
Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis
11小时前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
1天前
已完结
Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice
25天前
已完结
Update results of anlotinib combined with TQB2450 (PD-L1 blockade) as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicenter, open-label phase II clinical trial
2个月前
已完结
First-line TQB2450 plus anlotinib combined with paclitaxel and cisplatin for advanced esophageal squamous cell carcinoma (ESCC): Update results of a multicenter phase II trial
2个月前
已完结
Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer
2个月前
已完结
Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy
3个月前
已完结
CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor
3个月前
已完结
皖公网安备34019202002308
